{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:48:42Z","timestamp":1773326922685,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clinbiochem.2026.111104","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:10:52Z","timestamp":1771546252000},"page":"111104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TUG1 and miR-145 as potential biomarkers associating hypothyroidism to cardiovascular risk"],"prefix":"10.1016","volume":"142","author":[{"given":"Tarek K.","family":"Motawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidy","family":"Saied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-8307","authenticated-orcid":false,"given":"Noha H.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.clinbiochem.2026.111104_b0005","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/jama.2025.13559","article-title":"Hypothyroidism: a Review","volume":"334","author":"Chaker","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0010","unstructured":"A. Yasin El-Tayeb, \u201cAn Overview of Pathophysiology, Diagnosis, and Management of Hypothyroidism Corresponding Author*,\u201d J Diabetes Metab, vol. 16, p. 1203, 2025, doi: 10.35248\/2155-6156.10001203."},{"issue":"10101","key":"10.1016\/j.clinbiochem.2026.111104_b0015","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.clinbiochem.2026.111104_b0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12325-019-01080-8","article-title":"Hypothyroidism in context: where we\u2019ve been and where we\u2019re going","volume":"36","author":"Chiovato","year":"2019","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111104_b0025","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/biomedicines13061495","article-title":"Hashimoto\u2019s thyroiditis and female fertility: endocrine, immune, and microbiota perspectives in assisted reproduction\u2014a narrative review","volume":"13","author":"Popa","year":"2025","journal-title":"Biomedicines"},{"issue":"25","key":"10.1016\/j.clinbiochem.2026.111104_b0030","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/CIRCULATIONAHA.118.036859","article-title":"Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment","volume":"139","author":"Cappola","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0035","article-title":"The impact of thyroid disorder on cardiovascular disease: unraveling the connection and implications for patient care","volume":"55","author":"Soetedjo","year":"2024","journal-title":"IJC Heart Vasc."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111104_b0040","doi-asserted-by":"crossref","first-page":"Oct","DOI":"10.3892\/br.2024.1826","article-title":"Study of the association between thyroid dysfunction and serum lipid abnormalities","volume":"21","author":"Al-Odat","year":"2024","journal-title":"Biomed. Rep."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111104_b0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/eurheartj\/ehx050","article-title":"Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update","volume":"39","author":"Floriani","year":"2018","journal-title":"Eur. Heart J."},{"issue":"43","key":"10.1016\/j.clinbiochem.2026.111104_b0050","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.2174\/1381612826666201118094747","article-title":"Subclinical thyroid dysfunction and the risk of cardiovascular disease","volume":"26","author":"Stojkovi\u0107","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111104_b0055","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/clinem\/dgac417","article-title":"Effect of levothyroxine supplementation on the cardiac morphology and function in patients with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"107","author":"Wang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0060","doi-asserted-by":"crossref","unstructured":"V. Rajagopalan and A. M. Gerdes, \u201cPhysiological and Pathological Cardiac Remodeling in Altered Thyroid Hormone States,\u201d Thyroid and Heart: A Comprehensive Translational Essay, Second Edition, pp. 137\u2013152, Jan. 2020, doi: 10.1007\/978-3-030-36871-5_11.","DOI":"10.1007\/978-3-030-36871-5_11"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0065","doi-asserted-by":"crossref","unstructured":"P. Mantzouratou et al., \u201cThyroid Hormone and Heart Failure: Charting Known Pathways for Cardiac Repair\/Regeneration,\u201d Biomedicines 2023, Vol. 11, Page 975, vol. 11, no. 3, p. 975, Mar. 2023, doi: 10.3390\/BIOMEDICINES11030975.","DOI":"10.3390\/biomedicines11030975"},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111104_b0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10741-016-9554-7","article-title":"Thyroid hormones and cardiac remodeling","volume":"21","author":"Cokkinos","year":"2016","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111104_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0080","article-title":"Rethinking strategies for solving thyroid dysfunction at the heart of cardiovascular disease","volume":"2025","author":"Rajagopalan","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0085","doi-asserted-by":"crossref","unstructured":"L. Qi, J. Xing, Y. Yuan, and M. Lei, \u201cNoncoding RNAs in atherosclerosis: regulation and therapeutic potential,\u201d Molecular and Cellular Biochemistry 2023 479:5, vol. 479, no. 5, pp. 1279\u20131295, Jul. 2023, doi: 10.1007\/S11010-023-04794-0.","DOI":"10.1007\/s11010-023-04794-0"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0090","first-page":"1","article-title":"Non-coding RNAs in lipid metabolism and their roles in atherosclerosis","volume":"2026","author":"Sallam","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.06.011","article-title":"Long non-coding RNAs as new regulators of cardiac electrophysiology and arrhythmias: Molecular mechanisms, therapeutic implications and challenges","volume":"203","author":"Zhang","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.clinbiochem.2026.111104_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrcardio.2018.18","article-title":"Atherosclerosis: a new role for lncRNAs in atherosclerosis","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0110","doi-asserted-by":"crossref","unstructured":"Y. H. Lin, M. H. Wu, Y. H. Huang, C. T. Yeh, and K. H. Lin, \u201cTUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma,\u201d Cells 2020, Vol. 9, Page 262, vol. 9, no. 2, p. 262, Jan. 2020, doi: 10.3390\/CELLS9020262.","DOI":"10.3390\/cells9020262"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0115","article-title":"Circulating microRNAs as biomarkers for ischemic heart disease: a systematic review and gene set enrichment analysis","volume":"12","author":"Alcibahy","year":"2025","journal-title":"Front. Med. (lausanne)"},{"issue":"21","key":"10.1016\/j.clinbiochem.2026.111104_b0120","doi-asserted-by":"crossref","first-page":"Nov","DOI":"10.3390\/jcm14217454","article-title":"the heart\u2019s small molecules: the importance of microRNAs in cardiovascular health","volume":"14","author":"Yildiz","year":"2025","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111104_b0125","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111104_b0130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2018.05.049","article-title":"The lncRNA TUG1\/miR-145-5p\/FGF10 regulates proliferation and migration in VSMCs of hypertension","volume":"501","author":"Shi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111104_b0135","doi-asserted-by":"crossref","DOI":"10.1177\/1470320319868890","article-title":"Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study","volume":"20","author":"Ruszkowski","year":"2019","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111104_b0140","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/HYPERTENSIONAHA.120.15721","article-title":"Vascular effects of ACE (angiotensin-converting enzyme) inhibitors and statins in adolescents with type 1 diabetes","volume":"76","author":"Chiesa","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0145","doi-asserted-by":"crossref","unstructured":"T. Maruhashi et al., \u201cDiagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery,\u201d J. Am. Heart Assoc., vol. 9, no. 2, Jan. 2020, doi: 10.1161\/JAHA.119.013915.","DOI":"10.1161\/JAHA.119.013915"},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111104_b0150","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1113\/EP089482","article-title":"Individual variation of follicular phase changes in endothelial function across two menstrual cycles","volume":"106","author":"Liu","year":"2021","journal-title":"Exp. Physiol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111104_b0155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1113\/EP089716","article-title":"Variation in physiological function within and between menstrual cycles: uncovering the contributing factors","volume":"106","author":"McNulty","year":"2021","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0160","doi-asserted-by":"crossref","unstructured":"J. S. Williams, E. C. Dunford, and M. J. MacDonald, \u201cImpact of the menstrual cycle on peripheral vascular function in premenopausal women: systematic review and meta-analysis,\u201d https:\/\/doi.org\/10.1152\/ajpheart.00341.2020, vol. 319, no. 6, pp. H1327\u2013H1337, Dec. 2020, doi: 10.1152\/AJPHEART.00341.2020.","DOI":"10.1152\/ajpheart.00341.2020"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0165","doi-asserted-by":"crossref","unstructured":"J. Ambalavanan, \u201cUpdated Review of HOMA-IR (Homeostatic Model Assessment for Insulin Resistance),\u201d Evidence to Action: Official Journal of MDCalc, Dec. 2025, doi: 10.65357\/001C.154184.","DOI":"10.65357\/001c.154184"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0170","doi-asserted-by":"crossref","unstructured":"R. Dasgupta and S. P. Shetty, \u201cAssessment of insulin resistance: From the bench to bedside,\u201d Metabolic Syndrome: From Mechanisms to Interventions, pp. 351\u2013365, Jan. 2024, doi: 10.1016\/B978-0-323-85732-1.00053-0.","DOI":"10.1016\/B978-0-323-85732-1.00053-0"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111104_b0175","first-page":"6355","article-title":"miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"60","key":"10.1016\/j.clinbiochem.2026.111104_b0180","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22058","article-title":"Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.clinbiochem.2026.111104_b0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1261\/rna.5248604","article-title":"Fast and effective prediction of microRNA\/target duplexes","volume":"10","author":"Rehmsmeier","year":"2004","journal-title":"RNA"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0190","doi-asserted-by":"crossref","unstructured":"S. C. Russo, F. Salas-Lucia, and A. C. Bianco, \u201cDeiodinases and the Metabolic Code for Thyroid Hormone Action,\u201d Endocrinology, vol. 162, no. 8, p. bqab059, Aug. 2021, doi: 10.1210\/ENDOCR\/BQAB059.","DOI":"10.1210\/endocr\/bqab059"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-0716-4252-8_2","article-title":"Thyroid hormone action by genomic and nongenomic molecular mechanisms","volume":"2876","author":"Aranda","year":"2025","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0200","unstructured":"R. Sinha and P. M. Yen, \u201cCellular Action of Thyroid Hormone,\u201d Endotext, Jun. 2018, Accessed: Jan. 24, 2026. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK285568\/."},{"issue":"7","key":"10.1016\/j.clinbiochem.2026.111104_b0205","article-title":"Effect of levothyroxine therapy on the lipid profile of patients with hypothyroidism: a systematic review","volume":"16","author":"Nishat","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0210","unstructured":"P. Ushakiran, S. Kapoor, and J. Haria, \u201cEffect of Oxidative Stress Markers and Lipid Profile in Patients with Hypothyroidism,\u201d Frontiers in Health Informatics, vol. 13, no. 7, pp. 1063\u20131073, 2024, [Online]. Available: www.healthinformaticsjournal.com."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0215","doi-asserted-by":"crossref","unstructured":"H. Liu and D. Peng, \u201cUpdate on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism,\u201d Endocr. Connect., vol. 11, no. 2, Feb. 2022, doi: 10.1530\/EC-21-0002.","DOI":"10.1530\/EC-21-0002"},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111104_b0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12902-024-01779-y","article-title":"The association between thyroid function and insulin resistance as measured by the metabolic score for insulin resistance (METS-IR): insights from NHANES 2007\u20132012","volume":"24","author":"Safari","year":"2024","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111104_b0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13104-023-06516-7","article-title":"Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism","volume":"16","author":"Ostadrahimi","year":"2023","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0230","unstructured":"F. Monzani et al., \u201cRelationship between thyroid dysfunction and heart failure in older people,\u201d JOURNAL OF GERONTOLOGY AND GERIATRICS, vol. 65, no. 03 Special, pp. 184\u2013191, Sep. 2017, Accessed: Sep. 11, 2024. [Online]. Available: https:\/\/www.jgerontology-geriatrics.com\/article\/view\/140."},{"issue":"11","key":"10.1016\/j.clinbiochem.2026.111104_b0235","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/a-1018-9564","article-title":"Endothelial function in patients with subclinical hypothyroidism: a meta-analysis","volume":"51","author":"Gong","year":"2019","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2026.111104_b0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/HCO.0000000000000615","article-title":"Noncoding RNAs in cardiovascular diseases","volume":"34","author":"Gurha","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.04.066","article-title":"Long noncoding RNA\/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases","volume":"233","author":"Li","year":"2019","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111104_b0250","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00335-021-09895-z","article-title":"TUG1 knockdown suppresses cardiac fibrosis after myocardial infarction","volume":"32","author":"Sun","year":"2021","journal-title":"Mamm. Genome"},{"issue":"23","key":"10.1016\/j.clinbiochem.2026.111104_b0255","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/epi-2023-0242","article-title":"lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases","volume":"15","author":"Haybar","year":"2023","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111104_b0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41419-022-04805-w","article-title":"SP1-mediated up-regulation of lncRNA TUG1 underlines an oncogenic property in colorectal cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2026.111104_b0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.29368","article-title":"Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth","volume":"137","author":"Wu","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0270","doi-asserted-by":"crossref","unstructured":"C. Yang, Z. G. Cao, Z. W. Zhou, and S. J. Han, \u201cCirc0005654 as a new biomarker of thyroid cancer interacting with SP1 to influence the prognosis: A case-control study,\u201d Medicine (United States), vol. 102, no. 6, Feb. 2023, doi: 10.1097\/MD.0000000000032853.","DOI":"10.1097\/MD.0000000000032853"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.914506","article-title":"Long non-coding RNA NBAT1, TUG1, miRNA-335, and miRNA-21 as potential biomarkers for acute ischemic stroke and their possible correlation to thyroid hormones","volume":"9","author":"Mohammed","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carpath.2017.11.004","article-title":"TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1","volume":"33","author":"Zhang","year":"2018","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111104_b0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and cardiovascular disease risk","volume":"26","author":"Searles","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"issue":"5","key":"10.1016\/j.clinbiochem.2026.111104_b0290","doi-asserted-by":"crossref","first-page":"865","DOI":"10.17219\/acem\/62915","article-title":"MicroRNA in cardiovascular biology and disease","volume":"26","author":"Wojciechowska","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"issue":"24","key":"10.1016\/j.clinbiochem.2026.111104_b0295","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.3390\/ijms262412085","article-title":"The role of MicroRNAs in the pathophysiology and management of heart failure: from molecular mechanisms to clinical application","volume":"26","author":"Gilyazova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0300","unstructured":"X. Feng, F. Yao, Y. Lang, and Z. Cao, \u201cDownregulation of miR-145 alleviates ox-LDL-induced inflammation by targeting QKI in macrophages,\u201d Am. J. Transl. Res., vol. 14, no. 6, p. 4251, 2022, Accessed: Jan. 24, 2026. [Online]. Available: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9274569\/."},{"issue":"2","key":"10.1016\/j.clinbiochem.2026.111104_b0305","first-page":"2422","article-title":"LncRNA TUG1 serves an important role in hypoxia-induced myocardial cell injury by regulating the miR-145-5p-Binp3 axis","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.clinbiochem.2026.111104_b0310","doi-asserted-by":"crossref","first-page":"Sep","DOI":"10.3892\/etm.2021.10796","article-title":"Differentially expressed TUG1 and miR-145-5p indicate different severity of chronic heart failure and predict 2-year survival prognosis","volume":"22","author":"Zhu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0315","doi-asserted-by":"crossref","unstructured":"X. Guo et al., \u201cmiRNA-145 inhibits VSMC proliferation by targeting CD40,\u201d Scientific Reports 2016 6:1, vol. 6, no. 1, pp. 1\u201313, Oct. 2016, doi: 10.1038\/srep35302.","DOI":"10.1038\/srep35302"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0320","doi-asserted-by":"crossref","unstructured":"S. Gong et al., \u201cThe Crosstalk Between Endothelial Cells, Smooth Muscle Cells, and Macrophages in Atherosclerosis,\u201d International Journal of Molecular Sciences 2025, Vol. 26, Page 1457, vol. 26, no. 4, p. 1457, Feb. 2025, doi: 10.3390\/IJMS26041457.","DOI":"10.3390\/ijms26041457"},{"issue":"9","key":"10.1016\/j.clinbiochem.2026.111104_b0325","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1002\/jcp.28291","article-title":"miRNA-145-5p induces apoptosis after ischemia-reperfusion by targeting dual specificity phosphatase 6","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.clinbiochem.2026.111104_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120810","article-title":"miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype","volume":"273","author":"Chin","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.clinbiochem.2026.111104_b0335","doi-asserted-by":"crossref","unstructured":"K. V. Bulygin et al., \u201cCan miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis? \u2014Current Status,\u201d International Journal of Molecular Sciences 2020, Vol. 21, Page 6728, vol. 21, no. 18, p. 6728, Sep. 2020, doi: 10.3390\/IJMS21186728.","DOI":"10.3390\/ijms21186728"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912026000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:08:52Z","timestamp":1773277732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912026000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":67,"alternative-id":["S0009912026000329"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111104","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TUG1 and miR-145 as potential biomarkers associating hypothyroidism to cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2026.111104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111104"}}